Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Long term cardiac events

From: Red blood cell distribution width as long-term prognostic markers in patients with coronary artery disease undergoing percutaneous coronary intervention

Clinical outcomes Low RDW (n = 2894) High RDW (n = 3152) P value
Primary end point
 Long-term mortality, n (%) 113 (3.9%) 196 (6.2%) < 0.0001
Secondary endpoints
 Stroke, n (%) 35 (1.2%) 47 (1.5%) 0.344
 Readmission, n (%) 360 (12.4%) 459 (14.6%) 0.016
 MACEs, n (%) 317 (11.0%) 468 (14.8%) < 0.0001
 MACCEs, n (%) 351 (12.1%) 511 (16.2%) < 0.0001
 Cardiac death, n (%) 88 (3.0%) 163 (5.2%) < 0.0001
 Stroke, n (%) 35 (1.2%) 47 (1.5%) 0.344
 Bleeding events, n (%) 76 (2.6%) 99 (3.1%) 0.233
 Re-stent implantation 118 (4.1%) 143 (4.5%) 0.380
 Recurrent MI, n (%) 79 (2.7%) 115 (3.6%) 0.043
  1. MACCEs main adverse cardiovascular and cerebrovascular events, MACEs major adverse cardiac events, Recurrent MI recurrent myocardial infarction